SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022)
SELLAS Life Sciences (SLS) reported Asset Utilization Ratio of 0.04 for Q4 2022, down 82.0% year-over-year from 0.24 in Q4 2021, and up 24.0% quarter-over-quarter from 0.03 in Q3 2022.
SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022) Analysis & Trends
SELLAS Life Sciences (SLS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2022.
- Asset Utilization Ratio for Q4 2022 came in at 0.04, down 82.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 0.04 (down 82.0% YoY), and the FY2022 annual result was 0.04, down 79.85% from the prior year.
- Asset Utilization Ratio rose to 0.04 in Q4 2022 per SLS's latest filing, from 0.03 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.55 in Q1 2020 and troughed at 0.03 in Q3 2022.
- A 3-year average of 0.19 and a median of 0.19 in 2020 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio jumped 302.06% in 2021, then plunged 85.25% in 2022.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.06 in 2020, then soared by 302.06% to 0.24 in 2021, then plunged by 82.0% to 0.04 in 2022.
- Business Quant data shows SLS's Asset Utilization Ratio at 0.04 in Q4 2022, 0.03 in Q3 2022, and 0.04 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.23 |
| Mar 31, 2021 | 0.18 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.20 |
| Jun 30, 2020 | 0.39 |
| Mar 31, 2020 | 0.55 |
| Jun 30, 2015 | 0.10 |
| Mar 31, 2015 | 0.10 |
| Dec 31, 2014 | 0.12 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.11 |
| Mar 31, 2014 | 0.10 |
| Dec 31, 2013 | 0.10 |
| Sep 30, 2013 | 0.06 |